Andrew Litt

Andrew is responsible for providing strategic insight to Dell’s healthcare solutions. Today Andrew is going to talk about Dell’s project with the Traslational Genomics Institute which analyzes the genome of children with neuroblastoma to find the best matching cancer drug.